BDTX - Black Diamond Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - BDTX (1701541)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
24 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2020-10-15
BDTXVersant Venture Capital Vi, L.P.10%S - Sale$33.44-15,7468,821,1080%-$526,529
M
2020-10-15
BDTXBolzon Bradley J PhdDir, 10%S - Sale$33.44-15,7467,836,1750%-$526,529
M
2020-10-13
BDTXBolzon Bradley J PhdDir, 10%S - Sale$33.30-17,2407,850,0840%-$574,015
M
2020-10-13
BDTXVersant Venture Capital Vi, L.P.10%S - Sale$33.30-17,2408,836,8540%-$574,015
D
2020-10-12
BDTXHatzis-Schoch BrentSee RemarksS - Sale+OE$32.70-4,0783,000-58%-$133,331
M
2020-10-08
BDTXBolzon Bradley J PhdDir, 10%S - Sale$33.50-22,6257,865,3130%-$757,924
M
2020-10-08
BDTXVersant Venture Capital Vi, L.P.10%S - Sale$33.50-22,6258,854,0940%-$757,924
D
2020-10-08
BDTXLeggett ThomasCFOS - Sale+OE$33.53-3,0000-100%-$100,576
M
2020-10-06
BDTXBolzon Bradley J PhdDir, 10%S - Sale$33.44-45,92610,178-82%-$1,535,732
M
2020-10-06
BDTXVersant Venture Capital Vi, L.P.10%S - Sale$33.44-45,9265,756,660-1%-$1,535,732
D
2020-10-05
BDTXRoberts Christopher D.Chief Scientific OfficerS - Sale+OE$31.28-2,5000-100%-$78,188
D
2020-10-01
BDTXEpstein David M.See RemarksS - Sale+OE$30.33-12,000986,069-1%-$363,962
2020-09-30
BDTXIngram Robert AlexanderDirP - Purchase$30.46+5,0005,000New+$152,285
D
2020-09-14
BDTXHatzis-Schoch BrentSee RemarksS - Sale+OE$31.04-4,0783,000-58%-$126,583
D
2020-09-14
BDTXLeggett ThomasCFOS - Sale+OE$31.00-3,0000-100%-$93,000
D
2020-09-03
BDTXRoberts Christopher D.Chief Scientific OfficerS - Sale+OE$29.59-2,5000-100%-$73,987
M
2020-08-10
BDTXVersant Venture Capital Vi, L.P.10%S - Sale$33.06-13,79210,541,4690%-$455,989
M
2020-08-10
BDTXBolzon Bradley J PhdDir, 10%S - Sale$33.06-13,7929,417,1820%-$455,989
D
2020-02-03
BDTXVersant Venture Capital Vi, L.P.10%P - Purchase$19.00+894,7368,016,017+13%+$16,999,984
D
2020-02-03
BDTXBolzon Bradley J PhdDirP - Purchase$19.00+894,7361,206,603+287%+$16,999,984
D
2020-02-03
BDTXShah Rajeev M.DirP - Purchase$19.00+1,000,000353,814-155%+$19,000,000
2020-02-03
BDTXHatzis-Schoch BrentSee RemarksP - Purchase$19.00+3,0003,000New+$57,000
D
2020-02-03
BDTXBehbahani AliDirP - Purchase$19.00+800,0003,448,757+30%+$15,200,000
D
2020-02-03
BDTXFlynn James EPossible Member of 10% Group, 10%P - Purchase$19.00+400,000778,790+106%+$7,600,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top